首页 > 最新文献

Journal of the American Academy of Dermatology最新文献

英文 中文
re: Limitations of the commercially available gene expression test in predicting cutaneous squamous cell carcinoma metastasis and clinical outcomes.
IF 12.8 1区 医学 Q1 DERMATOLOGY
Journal of the American Academy of Dermatology
Pub Date : 2025-03-15 DOI: 10.1016/j.jaad.2025.02.092
Matthew S Goldberg, Victor Brodsky, Patrick Emanuel
{"title":"re: Limitations of the commercially available gene expression test in predicting cutaneous squamous cell carcinoma metastasis and clinical outcomes.","authors":"Matthew S Goldberg, Victor Brodsky, Patrick Emanuel","doi":"10.1016/j.jaad.2025.02.092","DOIUrl":"https://doi.org/10.1016/j.jaad.2025.02.092","url":null,"abstract":"","PeriodicalId":17198,"journal":{"name":"Journal of the American Academy of Dermatology","volume":" ","pages":""},"PeriodicalIF":12.8,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143649407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Supplemental Nutrition Assistance Program (SNAP) and Cost-Related Medical Care Delays in Pediatric Atopic Dermatitis: A Cross-Sectional Analysis of the National Health Interview Survey, 1999-2018.
IF 12.8 1区 医学 Q1 DERMATOLOGY
Journal of the American Academy of Dermatology
Pub Date : 2025-03-15 DOI: 10.1016/j.jaad.2025.03.025
Christopher G Youn, Arash Pour Mohammad, Ann L Marqueling, Dawn H Siegel, Justin M Ko, Gordon H Bae
{"title":"Association Between Supplemental Nutrition Assistance Program (SNAP) and Cost-Related Medical Care Delays in Pediatric Atopic Dermatitis: A Cross-Sectional Analysis of the National Health Interview Survey, 1999-2018.","authors":"Christopher G Youn, Arash Pour Mohammad, Ann L Marqueling, Dawn H Siegel, Justin M Ko, Gordon H Bae","doi":"10.1016/j.jaad.2025.03.025","DOIUrl":"https://doi.org/10.1016/j.jaad.2025.03.025","url":null,"abstract":"","PeriodicalId":17198,"journal":{"name":"Journal of the American Academy of Dermatology","volume":" ","pages":""},"PeriodicalIF":12.8,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143649403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ruxolitinib versus Roflumilast: A Meta-analysis of the Comparative Efficacy of Two Topical Therapies for Atopic Dermatitis.
IF 12.8 1区 医学 Q1 DERMATOLOGY
Journal of the American Academy of Dermatology
Pub Date : 2025-03-14 DOI: 10.1016/j.jaad.2025.03.019
Sana Gupta, Grace Xiong, Christopher Shenouda, Samantha Keow, Mohannad Abu-Hilal
{"title":"Ruxolitinib versus Roflumilast: A Meta-analysis of the Comparative Efficacy of Two Topical Therapies for Atopic Dermatitis.","authors":"Sana Gupta, Grace Xiong, Christopher Shenouda, Samantha Keow, Mohannad Abu-Hilal","doi":"10.1016/j.jaad.2025.03.019","DOIUrl":"https://doi.org/10.1016/j.jaad.2025.03.019","url":null,"abstract":"","PeriodicalId":17198,"journal":{"name":"Journal of the American Academy of Dermatology","volume":" ","pages":""},"PeriodicalIF":12.8,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143639604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Augmented Intelligence and Dermatology - Part I: Core Concepts and Applications. 增强智能与皮肤病学--第一部分：核心概念与应用。
IF 12.8 1区 医学 Q1 DERMATOLOGY
Journal of the American Academy of Dermatology
Pub Date : 2025-03-14 DOI: 10.1016/j.jaad.2024.09.090
Daniel Schlessinger, Justin Ko, Ivy Lee, Veronica Rotemberg, Roberto Novoa
{"title":"Augmented Intelligence and Dermatology - Part I: Core Concepts and Applications.","authors":"Daniel Schlessinger, Justin Ko, Ivy Lee, Veronica Rotemberg, Roberto Novoa","doi":"10.1016/j.jaad.2024.09.090","DOIUrl":"https://doi.org/10.1016/j.jaad.2024.09.090","url":null,"abstract":"","PeriodicalId":17198,"journal":{"name":"Journal of the American Academy of Dermatology","volume":" ","pages":""},"PeriodicalIF":12.8,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143639601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Augmented Intelligence and Dermatology - Part II: Bias, Benchmarks, Guidelines, Ethics, Regulation, and Future Directions.
IF 12.8 1区 医学 Q1 DERMATOLOGY
Journal of the American Academy of Dermatology
Pub Date : 2025-03-14 DOI: 10.1016/j.jaad.2024.10.132
Edwin Dovigi, Shannon Wongvibulsin, Ivy Lee, Rob Novoa, Zhuo Cai, Veronica Rotemberg, Roxana Daneshjou

Despite the proliferation of artificial intelligence (AI) tools, numerous challenges remain in the development and evaluation of AI related technologies. Furthermore, a practice gap exists in how to responsibly implement AI effectively, ethically, and legally in dermatology. Part 2 of this continuing medical education review series will explain the key technical challenges and principles of trustworthy and responsible AI as well as describe the ethical challenges and review resources to help guide safe, effective, and ethical AI in dermatology. This content will empower learners to critically analyze these tools and determine whether an AI solution is appropriate for their specific clinical need, patient, and practice setting.

{"title":"Augmented Intelligence and Dermatology - Part II: Bias, Benchmarks, Guidelines, Ethics, Regulation, and Future Directions.","authors":"Edwin Dovigi, Shannon Wongvibulsin, Ivy Lee, Rob Novoa, Zhuo Cai, Veronica Rotemberg, Roxana Daneshjou","doi":"10.1016/j.jaad.2024.10.132","DOIUrl":"https://doi.org/10.1016/j.jaad.2024.10.132","url":null,"abstract":"<p><p>Despite the proliferation of artificial intelligence (AI) tools, numerous challenges remain in the development and evaluation of AI related technologies. Furthermore, a practice gap exists in how to responsibly implement AI effectively, ethically, and legally in dermatology. Part 2 of this continuing medical education review series will explain the key technical challenges and principles of trustworthy and responsible AI as well as describe the ethical challenges and review resources to help guide safe, effective, and ethical AI in dermatology. This content will empower learners to critically analyze these tools and determine whether an AI solution is appropriate for their specific clinical need, patient, and practice setting.</p>","PeriodicalId":17198,"journal":{"name":"Journal of the American Academy of Dermatology","volume":" ","pages":""},"PeriodicalIF":12.8,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143639603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of Tuberculosis Screening in Psoriasis Patients Treated with Biologics and Traditional Immunosuppressant Medications: Experience at a Single U.S. Institution.
IF 12.8 1区 医学 Q1 DERMATOLOGY
Journal of the American Academy of Dermatology
Pub Date : 2025-03-14 DOI: 10.1016/j.jaad.2025.02.090
Blake Vest, Michael Buhnerkempe, Kenneth Minielly, Rebecca Larson
{"title":"Utility of Tuberculosis Screening in Psoriasis Patients Treated with Biologics and Traditional Immunosuppressant Medications: Experience at a Single U.S. Institution.","authors":"Blake Vest, Michael Buhnerkempe, Kenneth Minielly, Rebecca Larson","doi":"10.1016/j.jaad.2025.02.090","DOIUrl":"https://doi.org/10.1016/j.jaad.2025.02.090","url":null,"abstract":"","PeriodicalId":17198,"journal":{"name":"Journal of the American Academy of Dermatology","volume":" ","pages":""},"PeriodicalIF":12.8,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143639606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduced Major Adverse Cardiovascular Events (MACE) with Interleukin-17 Inhibitors Compared to Methotrexate in Psoriasis Patients: A multi-center retrospective cohort analysis. 与甲氨蝶呤相比，白细胞介素-17抑制剂可减少银屑病患者的主要心血管不良事件（MACE）：多中心回顾性队列分析。
IF 12.8 1区 医学 Q1 DERMATOLOGY
Journal of the American Academy of Dermatology
Pub Date : 2025-03-13 DOI: 10.1016/j.jaad.2025.03.014
Rahib K Islam, Alexander Maltese, Kazi N Islam, Jashin J Wu
{"title":"Reduced Major Adverse Cardiovascular Events (MACE) with Interleukin-17 Inhibitors Compared to Methotrexate in Psoriasis Patients: A multi-center retrospective cohort analysis.","authors":"Rahib K Islam, Alexander Maltese, Kazi N Islam, Jashin J Wu","doi":"10.1016/j.jaad.2025.03.014","DOIUrl":"https://doi.org/10.1016/j.jaad.2025.03.014","url":null,"abstract":"","PeriodicalId":17198,"journal":{"name":"Journal of the American Academy of Dermatology","volume":" ","pages":""},"PeriodicalIF":12.8,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143634185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retiform purpura.
IF 12.8 1区 医学 Q1 DERMATOLOGY
Journal of the American Academy of Dermatology
Pub Date : 2025-03-13 DOI: 10.1016/j.jaad.2025.03.017
Fatima Farrukh, Abraham M Korman
{"title":"Retiform purpura.","authors":"Fatima Farrukh, Abraham M Korman","doi":"10.1016/j.jaad.2025.03.017","DOIUrl":"https://doi.org/10.1016/j.jaad.2025.03.017","url":null,"abstract":"","PeriodicalId":17198,"journal":{"name":"Journal of the American Academy of Dermatology","volume":" ","pages":""},"PeriodicalIF":12.8,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143634190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cross-sectional analysis of mental health comorbidities in patients with prurigo nodularis. 对结节性瘙痒症患者精神健康合并症的横断面分析。
IF 12.8 1区 医学 Q1 DERMATOLOGY
Journal of the American Academy of Dermatology
Pub Date : 2025-03-13 DOI: 10.1016/j.jaad.2025.03.015
Daniela Frankel, Emily Ma, Davies Gage, Yagiz Matthew Akiska, Shahin Shahsavari, Shawn G Kwatra
{"title":"Cross-sectional analysis of mental health comorbidities in patients with prurigo nodularis.","authors":"Daniela Frankel, Emily Ma, Davies Gage, Yagiz Matthew Akiska, Shahin Shahsavari, Shawn G Kwatra","doi":"10.1016/j.jaad.2025.03.015","DOIUrl":"https://doi.org/10.1016/j.jaad.2025.03.015","url":null,"abstract":"","PeriodicalId":17198,"journal":{"name":"Journal of the American Academy of Dermatology","volume":" ","pages":""},"PeriodicalIF":12.8,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143634161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term Cardiovascular Safety of Ustekinumab in Psoriasis and Psoriatic Arthritis: Results from an Observational Post-Authorization Safety Study Based on Swedish National Registers.
IF 12.8 1区 医学 Q1 DERMATOLOGY
Journal of the American Academy of Dermatology
Pub Date : 2025-03-13 DOI: 10.1016/j.jaad.2025.03.016
Jonas Banefelt, Helena Skröder, Ahlem Azzabi, Anna Sheahan, Robert Suruki, Anja Geldhof

Background: Evidence on the comparative cardiovascular safety of ustekinumab in psoriasis (PsO) and psoriatic arthritis (PsA) remains limited.

Objective: To assess risk of major adverse cardiovascular events (MACE) among PsO and PsA patients treated with ustekinumab compared to those treated with adalimumab, etanercept, or secukinumab in routine clinical practice.

Methods: This new-user, active-comparator, observational cohort study used patient-level data from Swedish national registers, including adult PsO/PsA patients initiating treatment with ustekinumab or a comparator between 2009-2021, with patients assigned to mutually exclusive cohorts. The primary outcome was incident MACE, defined as myocardial infarction, ischemic stroke, or cardiovascular-related death. Adjusted hazard ratios (HR) were estimated using cause-specific Cox regression with stabilized inverse probability of treatment weighting by propensity scores.

Results: A total of 15,502 patients were included (852 ustekinumab-treated), with 147 MACE observed during follow-up. Adjusted HRs (95% CI) comparing ustekinumab to adalimumab, etanercept, and secukinumab were 1.07 (0.49-2.33), 1.08 (0.48-2.42), and 1.19 (0.46-3.10), respectively.

Limitations: Observational study, drug allocation not randomized, and lack of disease severity data.

Conclusion: This nationwide study of Swedish PsO/PsA patients spanning >10 years found no evidence of different cardiovascular safety profiles of ustekinumab versus adalimumab, etanercept, or secukinumab in real-world clinical practice.

{"title":"Long-term Cardiovascular Safety of Ustekinumab in Psoriasis and Psoriatic Arthritis: Results from an Observational Post-Authorization Safety Study Based on Swedish National Registers.","authors":"Jonas Banefelt, Helena Skröder, Ahlem Azzabi, Anna Sheahan, Robert Suruki, Anja Geldhof","doi":"10.1016/j.jaad.2025.03.016","DOIUrl":"https://doi.org/10.1016/j.jaad.2025.03.016","url":null,"abstract":"<p><strong>Background: </strong>Evidence on the comparative cardiovascular safety of ustekinumab in psoriasis (PsO) and psoriatic arthritis (PsA) remains limited.</p><p><strong>Objective: </strong>To assess risk of major adverse cardiovascular events (MACE) among PsO and PsA patients treated with ustekinumab compared to those treated with adalimumab, etanercept, or secukinumab in routine clinical practice.</p><p><strong>Methods: </strong>This new-user, active-comparator, observational cohort study used patient-level data from Swedish national registers, including adult PsO/PsA patients initiating treatment with ustekinumab or a comparator between 2009-2021, with patients assigned to mutually exclusive cohorts. The primary outcome was incident MACE, defined as myocardial infarction, ischemic stroke, or cardiovascular-related death. Adjusted hazard ratios (HR) were estimated using cause-specific Cox regression with stabilized inverse probability of treatment weighting by propensity scores.</p><p><strong>Results: </strong>A total of 15,502 patients were included (852 ustekinumab-treated), with 147 MACE observed during follow-up. Adjusted HRs (95% CI) comparing ustekinumab to adalimumab, etanercept, and secukinumab were 1.07 (0.49-2.33), 1.08 (0.48-2.42), and 1.19 (0.46-3.10), respectively.</p><p><strong>Limitations: </strong>Observational study, drug allocation not randomized, and lack of disease severity data.</p><p><strong>Conclusion: </strong>This nationwide study of Swedish PsO/PsA patients spanning >10 years found no evidence of different cardiovascular safety profiles of ustekinumab versus adalimumab, etanercept, or secukinumab in real-world clinical practice.</p>","PeriodicalId":17198,"journal":{"name":"Journal of the American Academy of Dermatology","volume":" ","pages":""},"PeriodicalIF":12.8,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143634168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
Journal of the American Academy of Dermatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1